Status:
COMPLETED
Pilot Study of the Ablative Fractional CO2 Laser in Hypertrophic Scars in Adult Burn Patients
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Burns
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This is a randomized, controlled, within-patient, single-blinded, pilot study that will evaluate the impact of laser treatment on burn HSc relative to self-matched control scars. The studied primary o...
Detailed Description
Prior to treatment initiation, two independent scars sites will be selected and an anatomically- on each individual. At the selected treatment site the scar will be treated with the CORE fractional CO...
Eligibility Criteria
Inclusion
- Fitzpatrick skin type \<IV (37),
- Have sustained a thermal burn injury,
- Have at least 2 independent sites that show clinical evidence of HSc,
- Are 2 months or more post-injury.
Exclusion
- Subjects with skin phototypes IV or higher,
- With history of keloidal scarring,
- Who have coagulation disorder,
- Are taking immunosuppressive medications,
- If the mechanism of injury is an electrical, chemical, or cold injury,
- Any underlying active skin disease,
- Have taken oral Isotreinoin within the last 6 months,
- Photosensitivity or have taken photosensitizing medications,
- Pregnancy,
- Previous treatment with dermabrasion, chemical peel, laser or intense pulsed light treatment
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03240718
Start Date
February 1 2015
End Date
December 1 2016
Last Update
August 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.